- Title
- Risk of cutaneous T-cell lymphoma in atopic dermatitis patients treated with dupilumab and JAK inhibitors: a TriNetX cohort study
- Creators
- Areeba Ahmed (Corresponding Author) - University of LouisvilleDylan Wambold - Drexel UniversityJoshua Burshtein - University of Illinois Urbana-ChampaignBrian Cahn - Columbia UniversityRoger Haber - University of Illinois Urbana-Champaign
- Publication Details
- Archives of dermatological research, v 318(1), 37
- Publisher
- Springer Nature
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Dermatology
- Web of Science ID
- WOS:001653243900002
- Scopus ID
- 2-s2.0-105026506799
- Other Identifier
- 991022196568104721
Journal article
Risk of cutaneous T-cell lymphoma in atopic dermatitis patients treated with dupilumab and JAK inhibitors: a TriNetX cohort study
Archives of dermatological research, v 318(1), 37
03 Jan 2026
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Metrics
3 Record Views
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
Source: SDGs in the Output
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Dermatology